Auscandoc<p>“In addition to the company’s $26,500 annual price tag for the drug, treatment could cost U.S. taxpayers $82,500 per patient per year, on average, for genetic tests and frequent brain scans, safety monitoring, and other care, according to estimates from the Institute for Clinical and Economic Review, or <a href="https://med-mastodon.com/tags/ICER" class="mention hashtag" rel="tag">#<span>ICER</span></a>.” <a href="https://med-mastodon.com/tags/dementia" class="mention hashtag" rel="tag">#<span>dementia</span></a> <a href="https://med-mastodon.com/tags/alzheimer" class="mention hashtag" rel="tag">#<span>alzheimer</span></a> <a href="https://mastodon.social/@br00t4c/110844632735576774" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">mastodon.social/@br00t4c/11084</span><span class="invisible">4632735576774</span></a></p>